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Abstract
This report details a general and enantioselective means for the synthesis of alkyl-substituted 
aziridines. This protocol offers a direct route for the synthesis of alkyl-substituted chiral aziridines 
from achiral starting materials. Readily accessed allylic hydroxylamine esters undergo copper 
hydride-catalyzed intramolecular hydroamination with a high degree of regio- and enantio-control 
to afford the aziridine products in good to excellent yield in highly enantioenriched form. The 
utility of the products derived from this method is further demonstrated through the derivatization 
of chiral aziridine products to a diverse array of functionalized enantioenriched amines.
Graphical abstract
Optically active aziridines constitute a key functional group present in several classes of 
natural products and pharmaceutical agents.1 Stereochemically well-defined aziridines also 
serve as useful building blocks or intermediates for the synthesis of a range of biologically 
active, nitrogen-containing compounds.2 For instance, aziridines readily participate in 
nucleophilic ring opening and ring expansion reactions, as well as in cycloadditions with 
dipolarophiles.2 Importantly, the stereochemistry embedded in the heterocycle can often be 
transferred to the final product to provide configurationally-pure amines. Consequently, a 
number of synthetic strategies for the stereoselective synthesis of aziridines have been 
developed.3 Prominent techniques include metal-catalyzed nitrene cycloadditions with 
olefins,4 carbene additions to imines,5 the aza-Darzens reaction,6 stereoselective azirine 
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reductions7 and C–H activation-based approaches.8 Despite the utility of these methods, 
they are generally limited to the preparation of aziridines with electron- withdrawing N-
substituents or require particular substitution patterns for productive reactivity. In general, 
alkyl-substituted aziridines, are especially challenging to access in a catalytic, 
enantioselective manner. One recent approach, disclosed by Lindsley, leverages the 
previously established enantioselective α-chlorination9 of aldehydes in a three-step one-pot 
protocol (Figure 1a).10 Nevertheless, no synthetic method allows for the direct preparation 
of chiral N-alkyl aziridines from achiral starting materials in a catalytic and asymmetric 
manner. We hypothesized that this synthetic challenge could be addressed through the 
intramolecular hydroamination of an allylic hydroxylamine ester 1, enabled by a 
catalytically generated chiral-phosphine ligated copper(I) hydride (CuH) species.
Recently, our group and others have adopted CuH catalysis as a general platform for the 
enantioselective hydrofunctionalization of olefins.11 Among these transformations, the 
enantioselective hydroamination was successfully applied to symmetric and unactivated 
internal olefins (Figure 1b).11e However, regioselectivity became problematic when 
unsymmetrical olefins were employed as substrates. Our own experience11c,e–k and an 
example from the recent literature11m suggested that a proximal polar substituent on alkenes 
could influence the regioselectivity of hydrocupration of the alkene by polarizing the C=C 
double bond. In the proposed aziridine synthesis (Figure 1c), we postulated that the presence 
of an allylic hydroxylamine ester would enforce the hydrocupration of the internal alkene to 
provide high regioselectivity for the desired regioisomer (favoring 2a over 2b). Following 
hydrocupration, the organocopper intermediate would undergo intramolecular amination to 
furnish chiral aziridine 3, in preference to the regioisomeric azetidine 4.
Allylic hydroxylamine ester 1aa (Table 1) was chosen as a model substrate to begin our 
study. Subjecting 1aa to a solution of CuH catalyst (generated from Cu(OAc)2, (S)-DTBM-
SEGPHOS (L1)) and a stoichiometric amount of dimethoxymethylsilane as the hydride 
source, resulted in the formation of the desired aziridine product 3a12 in 74% yield and 88% 
ee. Competing N–O bond reduction by the CuH catalyst accounted for the major side 
product, amine 5a. In order to suppress this deleterious reduction pathway, the reaction of 
substrates containing different hydroxylamine esters were examined. While use of electron-
deficient p-trifluoromethyl benzoate 1ab exhibited a higher tendency towards reduction, 
sterically hindered 2,4,6-trimethylbenzoate 1ad provided 3a in comparable yield but lower 
enantioselectivity (entries 2 and 4). The incorporation of electron-rich p-N,N-dimethylamino 
benzoate 1ac gave 3a in higher yield and improved enantioselectivity (80% yield, 94% ee, 
entry 3). By switching to pivalate 1ae, the enantioselectivity was further improved to 96% ee 
(entry 5). These last two results are in line with what we have seen in olefin hydroamination 
processes.13 In all cases, only a trace amount of the analogous azetidine was seen.14 Use of 
other commercially available chiral bisphosphine ligands (L2–L4) did not result in any 
enhancement over our initial choice of ligand, DTBM-SEGPHOS (L1) (entries 5–8). The 
bench-stable precomplexed copper catalyst (S)-CuCatMix13, consisting of a mixture of 
Cu(OAc)2/L1/PPh3 in a 1:1.1:1.1 ratio, offered a slightly improved yield and also simplified 
the reaction protocol (entry 9). Lastly, further optimization of reaction temperature (4 °C) 
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and concentration (1 M) allowed the desired product to be obtained in 89% yield by GC 
analysis (81% isolated yield) with an excellent level of enantioselectivity (98% ee, entry 10).
Having identified optimized conditions, the substrate scope of the N-substituent was 
explored (Table 2). In most cases, substituents on the nitrogen atom of varying electronic 
and steric properties were well-tolerated and their transformation proceeded with high yields 
and excellent enantioselectivities. In addition, an aziridine with a pendant aryl chloride (3e) 
was successfully prepared, allowing cross-coupling technology to be considered for 
downstream derivatization. A substrate containing a methyl ester and a free phenol (3i) was 
transformed to product with excellent efficiency and stereoselectivity. Moreover, structurally 
diverse N-alkyl groups including a silyloxyethyl (3j), a cyclohexyl (3k) and a simple methyl 
group (3l) could all be employed using our procedure. The presence of an ortho-isopropyl 
group on the N-benzyl substituent (3h) resulted in diminished enantioselectivity and 
represents a limitation of the current procedure, although a smaller ortho-methyl group (3g) 
was readily accommodated.
We next examined the scope of substituents that could be appended to the olefin (Table 3). 
The analogous 3-ethylaziridine 3m was successfully obtained from the corresponding crotyl 
hydroxylamine ester in 62% isolated yield and 93% ee. A benzyl ether (3n), an N-tosylate 
(3r), a silylether (3t), and a ketal (3v) were also compatible with the reaction conditions. 
Furthermore, high yields and enantioselectivities were observed in products derived from 
substrates that contained heterocyclic fragments. Among the substrates tested, a pyridine 
(3p), a quinoline (3q), a furan (3f, Table 2), a benzoxazole (3s), a benzothiazole (3t), and a 
tosyl-protected benzimidazoles (3r) were all well-tolerated under this CuH-catalyzed 
protocol. Substrates bearing large alkene substituents such as a diphenylmethyl (3l and 3o) 
and a cyclohexyl (3p) group also underwent the desired aziridination reaction without loss 
of efficiency or selectivity. Notably, other C=C double bonds in positions distal to the 
hydroxylamine ester (3u) were left intact, suggesting that the hydroxylamine ester group not 
only controls the regioselectivity but also activates the adjacent alkene for chemoselective 
hydrocupration. The presence of a homoallylic benzyl ether did not perturb the 
regioselectivity of the reaction (3n). Also, a hydroxylamine ester containing a chiral ketal 
group (1v) can be converted to aziridine 3v with greater than 20 : 1 diastereoselectivity. To 
demonstrate the scalability of this procedure, product 3o was synthesized on a 5.0 mmol 
scale. Full conversion of the substrate was achieved with a reduced catalyst loading of 0.5 
mol % to efficiently provide aziridine 3o (1.78 g of 3o, 90% yield, 98% ee).
During the course of our studies, we found that the nature of olefin geometry had a 
significant influence on reactivity and enantioselectivity. Under the optimized aziridination 
conditions, a low conversion of (Z)-1ae (Table 2) was observed, with only trace amounts of 
aziridine product 3a detected. Although full conversion could be achieved by raising the 
reaction temperature to 40 °C, the aziridine product 3a was obtained in only 12% isolated 
yield and 71% ee. The majority of the mass balance was accounted for by reductive cleavage 
of the N–O bond 5a, a side reaction exacerbated by the low reactivity of the (Z)-configured 
alkene.11g
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Chiral aziridines are well known as versatile intermediates in organic synthesis.2 To 
showcase the synthetic utility of N-alkyl aziridines, aziridine 3o was converted into a series 
of chiral amines (Scheme 1). Terminal aziridine 3o underwent regioselective ring opening 
with azide15 and acetic acid16 to provide chiral azido amine 6 and amino alcohol 8, 
respectively. Subjecting 3o to hydrogenation conditions provided chiral secondary amine 7. 
Further, LiI-catalyzed insertion of carbon dioxide into 3o afforded oxazolidones 9 as a 9.5 : 
1 mixture of regioisomers.17 In a reaction for which we could find no precedent, treatment 
of 3o with PPTS afforded chiral pyridinium salt 10·OTs, which allowed the absolute 
stereochemistry of aziridine product 3o to be established by X-ray crystallography.18
In summary, a highly enantioselective aziridination reaction was achieved through CuH-
catalyzed regioselective intramolecular hydroamination. The mild reaction conditions of this 
protocol allow for compatability of a wide range of functional groups and heterocyclic 
substitutents. Efforts to extend this intramolecular hydroamination strategy to encompass 
more types of nitrogen-containing heterocycles are currently under way.
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Figure 1. 
Lindsley’s approach for the synthesis of chiral N-alkyl aziridines and the development of our 
strategy.
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Scheme 1. 
N-alkyl aziridine derivatizationa and X-ray crystallographic structure of 10
aReaction conditions: a) TMSN3 (5 equiv), AcOH (5 equiv), MeCN, rt. b) Pd/C (10 mol %), 
H2 (1 atm), MeOH, rt. c) AcOH (5 equiv), CH2Cl2, rt. d) LiI (1 equiv), CO2 (1 atm), 40 °C. 
e) PPTS (1.5 equiv), CH2Cl2, rt.
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Table 2
Substrate scope of CuH-catalyzed chiral aziridine synthesis – variation of substitution on the nitrogen atoma
aAll yields represent average isolated yields of two runs conducted on a 0.5 mmol scale.
b40 °C reaction temperature.
c5 mol % catalyst used.
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d3 equivalents of (MeO)2MeSiH were used.
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Table 3
Substrate scope of alkene substituents and heterocyclic substituentsa
aAll yields represent average isolated yields of two runs conducted on a 0.5 mmol scale.
b5.0 mmol scale, 0.5 mol % catalyst used, 40 h reaction time.
c5 mol % catalyst used.
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d48 h reaction time.
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